Thromboembolic Complications in Severe COVID-19: Current Antithrombotic Strategies and Future Perspectives-Reference-Cited by-同舟云学术

Thromboembolic Complications in Severe COVID-19: Current Antithrombotic Strategies and Future Perspectives

Published:2021-03 Issue:1 Volume:21 Page:23-29
ISSN:1871-529X
Container-title:Cardiovascular & Hematological Disorders-Drug Targets
language:en
Short-container-title:CHDDT

Author:

Rodriguez Juan J.¹^ORCID,Munoz Oscar C.²^ORCID,Porres-Aguilar Mateo³^ORCID,Mukherjee Debabrata⁴^ORCID

Affiliation:

1. Facultad de Medicina, Universidad Autonoma Bucaramanga, Bucaramanga, Colombia

2. Department of Interventional Cardiology, Del Sol Medical Center, El Paso, TX 79925, United States

3. Division of Adult Thrombosis Medicine, Centre of Excellence in Thrombosis and Anticoagulation Care (CETAC) at Jewish General Hospital, Department of Medicine, McGill University, Montreal, Quebec, Canada

4. Division of Cardiovascular Diseases, Department of Medicine, Texas Tech University Health Sciences Center at El Paso, El Paso, TX 79905, United States

Abstract

The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus (SARS- CoV-2) is our latest pandemic and has turned out to be a global public health crisis. One of the special characteristics of this disease is that it may predispose patients to thrombotic disease both in the venous and arterial circulation. We review arterial and venous thromboembolic complications in patients with COVID-19, epidemiology, pathogenesis, hematologic biomarkers, and current antithrombotic strategies. Future perspectives and clinical trials are ongoing to determine the best thromboprophylaxis strategies in the hospitalized patients with severe COVID-19.

Publisher

Bentham Science Publishers Ltd.

Subject

Cardiology and Cardiovascular Medicine,Pharmacology,Hematology,Molecular Medicine,General Medicine

Reference50 articles.

1. Wheeler D.M.S.; Wheeler M.M.; WHO cases to date.

2. Zhou F.; Yu T.; Du R.; Fan G.; Liu Y.; Liu Z.; Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020,395(10229),1054-1062

3. Lan J.; Ge J.; Yu J.; Shan S.; Zhou H.; Fan S.; Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 2020,581(7807),215-220

4. Ruan Q.; Yang K.; Wang W.; Jiang L.; Song J.; Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020,46(5),846-848

5. Menter T.; Haslbauer J.; Nienhold R.; Savic S.; Hopfer H.; Deigendesch N.; Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology 2020,77(2),198-209

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 in patients with congenital bleeding disorders in Russia;Russian journal of hematology and transfusiology;2023-07-20

2. COVID-19 IN PATIENTS WITH CONGENITAL BLEEDING DISORDERS IN RUSSIA;GEMATOL TRANSFUZIOL;2023

3. Contemporary Treatment of Pulmonary Embolism: Medical Treatment and Management;International Journal of Angiology;2022-07-19

4. Congenital Bleeding Disorders and COVID-19 - An Emphasis on the Role of Thrombosis as One of the Main Causes of Morbidity and Mortality in COVID-19;Cardiovascular & Hematological Disorders-Drug Targets;2022-06